‘Contingency on contingency’: Judge won’t halt IP dispute over Abilify generic
Intellectual Property 2024-11-01 11:18 pm By Sam Matthews | Melbourne
Please login to bookmark Close

The Commonwealth has lost its bid to pause a long-running dispute over a generic form of brand drug Abilify while the High Court hears a different generic drug battle.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au